Christopher J. Joyce Sells 30,939 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Key Points

• Alignment Healthcare insider Christopher Joyce sold 30,939 shares for a total of $507,708.99, reducing his ownership by 8.26%.
• The company's stock price is currently at $16.45, with analysts providing a consensus rating of Moderate Buy and an average target price of $18.83.
• For the last quarter, Alignment Healthcare reported a revenue of $1.02 billion, exceeding analyst estimates and marking a 49% increase year-over-year.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Christopher J. Joyce sold 30,939 shares of the company's stock in a transaction that occurred on Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total transaction of $507,708.99. Following the completion of the transaction, the insider owned 343,592 shares in the company, valued at approximately $5,638,344.72. This represents a 8.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Alignment Healthcare Trading Up 1.7%

Shares of ALHC stock traded up $0.28 during trading hours on Monday, hitting $16.32. The company had a trading volume of 4,336,879 shares, compared to its average volume of 3,638,717. The company's fifty day moving average is $14.47 and its 200 day moving average is $15.54. The company has a debt-to-equity ratio of 2.29, a current ratio of 1.66 and a quick ratio of 1.66. Alignment Healthcare, Inc. has a fifty-two week low of $9.15 and a fifty-two week high of $21.06. The stock has a market capitalization of $3.23 billion, a PE ratio of -58.28 and a beta of 1.17.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of ($0.07) by $0.14. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $960.25 million. During the same period in the prior year, the business posted ($0.13) EPS. The business's revenue for the quarter was up 49.0% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Research analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Alignment Healthcare

A number of large investors have recently modified their holdings of ALHC. Wellington Management Group LLP increased its position in shares of Alignment Healthcare by 77.9% in the 4th quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company's stock valued at $83,683,000 after purchasing an additional 3,257,630 shares during the last quarter. Millennium Management LLC increased its position in shares of Alignment Healthcare by 588.3% in the 4th quarter. Millennium Management LLC now owns 3,388,602 shares of the company's stock valued at $38,122,000 after purchasing an additional 2,896,311 shares during the last quarter. Invesco Ltd. boosted its holdings in shares of Alignment Healthcare by 122.3% in the 2nd quarter. Invesco Ltd. now owns 4,170,529 shares of the company's stock valued at $58,387,000 after buying an additional 2,294,739 shares in the last quarter. Point72 Asset Management L.P. acquired a new position in shares of Alignment Healthcare in the 4th quarter valued at $20,087,000. Finally, Vanguard Group Inc. boosted its holdings in shares of Alignment Healthcare by 13.2% in the 1st quarter. Vanguard Group Inc. now owns 11,113,896 shares of the company's stock valued at $206,941,000 after buying an additional 1,295,825 shares in the last quarter. 86.19% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on ALHC shares. KeyCorp raised shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 target price on the stock in a research note on Monday, August 25th. Stephens raised shares of Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Barclays raised shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and upped their target price for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st. Wall Street Zen downgraded shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, August 10th. Finally, Zacks Research raised shares of Alignment Healthcare to a "hold" rating in a research note on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $18.83.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.